AVCR Share Price Performance
CA$0.065
-0.13 (-65.79%)
Price CA$0.065
Share PriceCA$0.065
Avricore Health Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 2 Fair Values set on narratives written by author
AVCR Community Narratives
There are no narratives available yet.
Recent AVCR News & Updates
Avricore Health Inc. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.014
- Gross Margin
- 42.97%
- Net Profit Margin
- -46.38%
- Debt/Equity Ratio
- 0%
Avricore Health Inc. Competitors
Snowflake Analysis
About AVCR
- Founded
- 1996
- Employees
- n/a
- CEO
- WebsiteView website
Avricore Health Inc. engages in the health data and point-of-care technologies business. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.
Market Insight
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
Canadian Market Performance
- 7 Days: 0.4%
- 3 Months: 10.0%
- 1 Year: 21.2%
- Year to Date: 19.9%
The market has been flat over the last week. As for the longer term, the market has risen 21% in the past 12 months. As for the next few years, earnings are expected to grow by 12% per annum. Market details ›